Furthermore, the protective effects observed in human cardiomyocyte cell lines suggest that GDF15 may have broad applicability across different cell types, potentially extending its therapeutic relevance to other cardiovascular diseases. This evidence concerns the gene GDF15 and cardiovascular disorder.